Brian Olshansky, MD, FACC, FAHA, FHRS, Board-certified clinical cardiac electrophysiologist, is a Professor Emeritus of Medicine at University of Iowa Hospitals and Clinics and a practicing clinical cardiac electrophysiologist at Mercy Medical Center in Mason City, IA and Covenant Medical Center in Waterloo, Iowa.
Dr. Olshansky graduated with distinction from Carleton College in Northfield, Minnesota, with a major in Chemistry. He then moved to Tucson, Arizona where he was a pulmonary function technician at the VA Hospital and was involved in surfactant research. That is where he developed a love for medicine. He attended the University of Arizona Medical School and received his MD from there. During his career, Dr. Olshansky has had faculty positions at Case Western Reserve University, Loyola University, and The University of Iowa in Iowa City. He has directed Electrophysiology Laboratories and Training Programs at Loyola University Medical Center and University of Iowa Hospitals & Clinics.
Dr. Olshansky has expertise in the evaluation and treatment of cardiac arrhythmias using state-of-the-art techniques, including device implantation (pacemakers and implanted defibrillators) and catheter ablation techniques for atrial fibrillation and ventricular tachycardia. He has specific expertise in issues regarding autonomic effects on the heart and cardiovascular system, specifically related to the parasympathetic nervous system. He is recognized for his work regarding the assessment of arrhythmia mechanisms, multicenter randomized clinical trials, treatment of atrial and ventricular arrhythmias, and evaluation of syncope.
Dr. Olshansky’s research has focused on the treatment for, and mechanism of, atrial and ventricular arrhythmias, on syncope, on athletes with cardiovascular conditions, and on anticoagulation, among other interests. He has been involved in numerous clinical trials and has published over 200 peer-reviewed manuscripts, as well as many other publications, including three books. He is, or has been, a member of over 20 editorial boards, reviewed regularly for three NIH study sections for over 10 years, and reviews for over 65 medical journals.